Adenik is a preparation containing tamsulosin hydrochloride 0.4 mg in modified-release capsules, manufactured by RafPharmi Co. The product is used in urological practice for male lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) — the same active substance as the reference brand Omnic, in an accessible formulation.
Tamsulosin selectively blocks alpha-1A adrenergic receptors concentrated in the prostate, bladder neck and urethra. Blocking these receptors relaxes the smooth muscles around the prostate and bladder outlet: urine flow improves, and BPH symptoms — weak stream, hesitancy, nocturia, incomplete emptying — decrease.
The alpha-1A selectivity is the key advantage: minimal blood-pressure impact compared to non-selective alpha-blockers.
Adenik is prescribed by urologists for:
The medication is prescription-only and used under urologist supervision.
The most commonly reported adverse reactions:
Caution with concurrent PDE5 inhibitors (sildenafil, tadalafil) and antihypertensives — combinations are adjusted by the physician. Medical attention should be sought for fainting or severe dizziness.
Patients undergoing cataract or glaucoma surgery must inform the surgeon about tamsulosin use (intraoperative floppy iris syndrome, IFIS).
Same active substance — tamsulosin 0.4 mg. Omnic (Astellas) is the original reference brand with the OCAS controlled-release tablet; Adenik (RafPharmi) is an accessible modified-release capsule. Both are European products; the choice is about availability, price and formulation preference.
Standard modified-release tamsulosin capsules are taken approximately 30 minutes after the same meal each day for stable absorption. If your daily routine doesn't allow food-timing, ask your physician about the OCAS tablet form (Omnic Ocas), which is food-independent.
Flow improvements often appear within days; full benefit in 2–4 weeks. If symptoms don't improve after a month, the urologist reviews the diagnosis and may add a 5-AR inhibitor (e.g., dutasteride) for long-term prostate-volume reduction.
Yes — the alpha-blocker + 5-AR inhibitor combination is a documented standard in moderate-to-severe BPH: tamsulosin addresses symptoms quickly, dutasteride shrinks the prostate long-term. Combination is prescribed and monitored by the urologist.
Yes. Adenik is a prescription medication. Regular urological review, blood pressure control and eye-surgery notification (IFIS) are standard practice.
Ask a question or inquire about delivery to your country
